[VRTX] YoY Quarter Result on 31-Dec-2015 [#Q4]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
16-Feb-2016
Financial Year
2015
Quarter
31-Dec-2015 [#Q4]
Profit Trend
QoQ- 20.64%
YoY- 57.25%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Revenue 870,106 651,634 458,706 417,935 144,556 351,157 333,994 17.29%
PBT 32,497 112,442 20,306 -77,829 -178,594 -340,253 -80,772 -
Tax -1,492,599 10,257 -7,453 -1,379 2,043 -155,704 -2,696 186.41%
NP 1,550,527 100,684 32,945 -75,512 -176,656 44,285 -76,148 -
Tax Rate 4,593.04% -9.12% 36.70% - - - - -
Total Cost -680,421 550,950 425,761 493,447 321,212 306,872 410,142 -
Ratio Analysis
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
NP Margin 178.20 15.45 7.18 -18.07 -122.21 12.61 -22.80 -
Per Share
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
EPS 6.08 0.40 0.13 -0.31 -0.74 0.19 -0.35 -
EPS Diluted 5.97 0.39 0.13 -0.31 -0.74 0.19 -0.35 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.